Multiple sclerosis is a serious condition that affects the nervous system. For years, doctors have struggled to understand exactly when the disease starts or how to catch it early. A new narrative review offers a fresh perspective. It proposes that multiple sclerosis should be seen as a continuum rather than a sudden event. This shift in thinking could change how doctors manage care for individuals at higher risk for the disease.
The authors argue that this new way of thinking might lead to better risk stratification. They hope it will also help develop targeted monitoring strategies. These strategies could catch the disease earlier or manage it more effectively before symptoms become severe. The goal is to improve outcomes for patients who are currently waiting for a clear diagnosis.
However, the review notes some important gaps in current knowledge. There are no biomarkers with enough specificity to reliably track preclinical or prodromal biological disease activity. Additionally, there are no validated tools to translate these findings into clinical practice right now. Without these tools, the new conceptual framework remains a guide for future research rather than an immediate change in daily care.